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The magnitude of shigellosis in developing countries is largely unknown because an affordable detection method is not available.
Current laboratory diagnosis of Shigella spp. is laborious and time consuming and has low sensitivity. Hence, in the present study,
a molecular-based diagnostic assay which amplifies simultaneously four specific genes to identify invC for Shigella genus, rfc for S.
flexneri,wbgZ for S. sonnei, and rfpB for S. dysenteriae, aswell as one internal control (ompA) gene, was developed in a single reaction
to detect and differentiate Shigella spp. Validation with 120 Shigella strains and 37 non-Shigella strains yielded 100% specificity. The
sensitivity of the PCR was 100 pg of genomic DNA, 5.4 × 104 CFU/ml, or approximately 120CFU per reaction mixture of bacteria.
The sensitivity of the pentaplex PCR assay was further improved following preincubation of the stool samples in Gram-negative
broth. A preliminary study with 30 diarrhoeal specimens resulted in no cross-reaction with other non-Shigella strains tested. We
conclude that the developed pentaplex PCR assay is robust and can provide information about the four target genes that are essential
for the identification of the Shigella genus and the three Shigella species responsible for the majority of shigellosis cases.
1. Introduction
Shigellosis continues to be a major health problem in many
parts of the world, particularly in underdeveloped and devel-
oping countries with poor sanitary systems and improper
treatment of water supplies, and also among travelers from
industrialized nations [1, 2]. Worldwide, mortality and mor-
bidity due to shigellosis were found to be highest among
young children 1 to 5 years of age and the elderly [3–5].Three
species of Shigella are responsible for the majority of shigel-
losis cases: S. flexneri, S. sonnei, and S. dysenteriae. Of these, S.
sonnei is encountered mostly in industrialized countries and
S. flexneri in developing countries; S. dysenteriae is the only
epidemic and pandemic strain [2, 4, 6, 7].The pathogenesis of
shigellosis includes inflammation, ulceration, haemorrhage,
tissue destruction, and fibrosis of the colonic mucosa, which
result in abdominal pain and diarrhoea/dysentery; in some
cases infertility and endometriosis also have been reported [8,
9]. Bacteraemia may occur in people with severe infections,
particularly inmalnourished children andAIDSpatients [10].
A more recent annual estimate of shigellosis throughout the
world was estimated to be 90 million incidences and 108,000
deaths [11].
Shigella infection spreads by the faecal-oral route.
Because of the low infectious dose (10 to 100 organisms),
person-to-person transmission is likely the most common
route of infection, as the bacteria can survive gastric acidity
better than other enteric bacteria [10, 12]. However, transmis-
sion via contaminated water, food, overcrowded communi-
ties, food handlers, contaminated swimming pools, and flies
also has been documented [8, 13, 14]. Recent increases in the
number of cases of shigellosis in many parts of the world
are attributed to the emergence of multiple-drug resistant
strains. Early and accurate diagnosis of shigellosis coupled
with promptmedical intervention is essential for reducing the
morbidity and mortality caused by Shigella spp.
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Shigella spp. are fragile organisms that are excreted in
large numbers in the stool, but they die off quickly because
stools are acidic [15]. Thus, routine microbiological methods
used to identify Shigella spp. from stool samples are relatively
inefficient, time consuming, and labor intensive, and the
diagnosis often remains obscure due to the presence of low
numbers of causative organisms, competition from other
commensal organisms, and inappropriate sample collection.
If samples are collected after antibiotic therapy, growth of the
organism may be impaired. Moreover, Dutta et al. [16] and
Islam et al. [17] reported the sensitivity of the culture method
to be 54% and 74%, respectively, compared to that of the
conventional PCR technique. Recent molecular diagnostic
techniques based on nucleic acids, such as PCR, have shown
tremendous potential for identifying Shigella spp. and have
been increasingly exploited.
To date, few studies have focused on the rapid diagnosis
of shigellosis in underdeveloped and developing countries.
However, PCR diagnostic tests have proven to be rapid and
effective for the detection and identification to Shigella spp.
[16–18]. In this study, we searched for genes unique to the
Shigella serovars and used them to design a pentaplex PCR
assay. Our assay differs from conventional multiplex PCRs,
which often target the invasion plasmid H (ipaH) gene, O
antigen synthesis genes, and the 16S rRNA gene for detection
of Shigella spp. [18–20]; in those cases, the diagnosis is often
based on sequence polymorphisms or differences rather than
on the absence or presence of a gene. Those methods do not
detect Shigella at the genus and species level simultaneously.
The goal of the present studywas to design a pentaplex PCRof
Shigella spp. with an internal control for the detection of the
genus Shigella and also for the clinically important Shigella
spp., namely, S. flexneri, S. sonnei, and S. dysenteriae.
2. Methods
2.1. Bacterial Strains and Growth Conditions. A total of 120
Shigella strains of S. flexneri (𝑛 = 95), S. sonnei (𝑛 = 20),
S. dysenteriae (𝑛 = 3) and S. boydii (𝑛 = 2), were used in
this study. Pure culture strains were isolated from patients
admitted toHospital Universiti SainsMalaysia (HUSM) from
2001 to 2009. Table 2 lists the Shigella spp. reference strains
and other bacteria used in this study. Non-Shigella strains
were used to determine the specificity and robustness of the
assay. All the strains were biochemically and serologically
confirmed and were stored at −80∘C in 16% glycerol.
2.2. Isolation of Shigella Spp. from Clinical Specimens Using a
Conventional Method. Stool specimens were inoculated on
MacConkey (Oxoid Ltd., UK) and deoxycholate citrate agar
(DCA) (Oxoid Ltd., UK) using a sterile inoculating loop.
Stools were also enriched in selenite F broth (Oxoid Ltd.,
UK) and incubated overnight at 37 ± 2∘C. The next day,
the enriched broth was subcultured on MacConkey agar and
DCA and incubated overnight at 37±2∘C. Colonies morpho-
logically resembling Shigella spp. were further evaluated with
biochemical tests using triple sugar iron (Oxoid Ltd., UK),
urea agar slant (Oxoid Ltd., UK), methyl red (Oxoid Ltd.,
UK), Simmon’s citrate agar slant (Oxoid Ltd., UK), and sul-
phur indole motility medium (Oxoid Ltd., UK). Identities of
colonies were serologically confirmed by slide agglutination
with appropriate group-specific polyvalent antisera followed
by type-specific monovalent antisera (Denka-Seiken, Tokyo,
Japan). Nonserotypable isolates were further checked using
an API 20E kit (BioMerieux, Marcy I’Etoile, France).
2.3. Primer Design for Pentaplex PCR Assay. The gene
sequence for invC of the genus Shigella and gene sequences for
rfc, wbgZ, and rfpB of S. flexneri, S. sonnei, and S. dysenteriae,
respectively, were obtained from GenBank [21] for DNA
sequence alignment and primer design. The ClustalW pro-
gram in Vector NTI version 9.0 software (Invitrogen, Carls-
bad, CA, USA) was used to align the DNA sequences. The
conserved and non-conserved regions of the DNA sequence
alignments were visualized using GeneDoc software [22].
Based on the conserved regions of the alignment, specific
primer pairs for the genus Shigella were designed to amplify
the invC gene. Specific primers for S. flexneri, S. sonnei, and
S. dysenteriae were designed based on the non-conserved
regions of rfc, wbgZ, and rfpB genes, respectively. The four
primer pairs were designed in such a way that amplification
efficiency was not hindered and amplicon sizes ranging
from 211 to 875 bp could be differentiated by agarose gel
electrophoresis (Figure 1). The homology of the designed
primer sequences was analyzed using BLAST [21]. A primer
pair based on the ompA gene was designed (1319 bp) and
used as an internal control. The primer (AIT BIOTECH,
Singapore) sequences for the five genes and expected PCR
product sizes are shown in Table 1.
2.4. Pentaplex PCR Assay. The pentaplex PCR assay was
standardized using genomic DNA extracted from reference
Shigella spp. A mixture of DNA from three strains (S. flexneri
(SH052), S. sonnei (SH023), and S. dysenteriae (SD375)) that
contained the four genes of interest was used as a positive
control. DNase-free distilled water was used as a negative
control. In addition, a plasmid containing the ompA gene
(10 pg) was incorporated as an internal control template to
rule out false negative results. An internal control (primer
pair and template) was incorporated into every reaction
mixture, including negative controls.
The colonies isolated from blood agar were inoculated
into nutrient agar (Oxoid Ltd., UK) and incubated overnight
at 37 ± 2∘C. Bacteria lysate was prepared by resuspending
one bacterial colony in 30 𝜇L of deionized water, boiling for
5min, and centrifuging at 8000 ×g for 2min. Twomicroliters
of supernatant then were used as the DNA template in the
pentaplex PCR assays.
The optimized primer concentration for each gene
(0.4 pmol for ompA, rfc, and rfpB; 0.3 pmol for invC; and
0.2 pmol for wbgZ) was used in the pentaplex PCR. The
other components used in the PCR were 200𝜇M dNTPs,
2.5mMMgCl
2
, 1X PCR buffer, and 1 U TaqDNA polymerase
(Promega, Madison, WI, USA). The PCR was performed
using a Mastercycler Gradient (Eppendorf, Hamburg, Ger-
many)with one cycle of initial denaturation at 94∘C for 3min,
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Figure 1: Pentaplex PCR assay profile with reference strains. M, 100 bp plus marker; lane 1, negative control; lane 2, positive control; lane 3,
SH052 strain (rfc S. flexneri, invC-Shigella genus); lane 4, SH031 strain (invC-Shigella genus,wbgZ S. sonnei); lane 5, SD375 strain (invC-Shigella
genus, rfpB S. dysenteriae); M, 100 bp plus marker.
Table 1: Sequences of primers used for the pentaplex PCR.
Primers Primer sequence (5󸀠-3󸀠) Gene target Location of gene Amplicon size(bp) Target identity
GenBank accession
number
SgenDF1 TGC CCA GTT TCT TCA TAC GC invC Plasmid 875 Shigella genus AF386526
SgenDR1 GAA AGT AGC TCC CGA AAT GC
SflexDF1 TTT ATG GCT TCT TTG TCG GC rfc Chromosome 537 Shigella flexneri CP000266
SflexDR1 CTG CGT GAT CCG ACC ATG
SsonDF1 TCT GAA TAT GCC CTC TAC GCT wbgZ Plasmid 430 Shigella sonnei CP000039
SsonDR1 GAC AGA GCC CGA AGA ACC G
SdysDF1 TCT CAA TAA TAG GGA ACA CAG C rfpB Plasmid 211 Shigella dysenteriae CP000640
SdysDR1 CAT AAA TCA CCA GCA AGG TT
ICDF1 GCA GGC ATT GCT GGG TAA ompA Plasmid 1319 Internal control AY305875
ICDR1 ACA CTT GTA AGT TTT CAA CTA CG
30 cycles of denaturation at 94∘C for 30 s, annealing for 30 s at
60∘C, and extension at 72∘C for 30 s, followed by an extra cycle
of annealing at 60∘C for 30 s and a final extension at 72∘C for
3min. The PCR products were analyzed by electrophoresis
on 1.5% agarose gels (Promega) with 10mg/mL ethidium
bromide (Sigma, USA); they were run at 100V for 60min.
PCR products were visualized under a UV transilluminator
and photographed using an image analyzer (ChemiImager
5500; Alpha Innotech, San Leandro, CA, USA).
2.5. Evaluation of Pentaplex PCR Assay Results. Analytical
specificity was evaluated using DNA lysate prepared from
pure cultures of 120 Shigella strains, 10Gram-positive strains,
and 27 Gram negative strains. The analytical sensitivity was
evaluated using genomic DNA (1𝜇g to 10 pg) and also 108 to
102 CFU/mL obtained from Shigella strains. The diagnostic
evaluation of the pentaplex PCR was conducted using 95 S.
flexneri, 20 S. sonnei, 3 S. dysenteriae, and 2 S. boydii strains.
The results were compared with those from the conventional
culture method, which is considered to be the standard of
detection [23].
2.6. Faecal Spiking and Sensitivity. The standardized penta-
plex PCR assay designed to detect Shigella directly from stool
was also tested using stool samples spiked with a known
amount of Shigella based on slight modification of method
described by Houng et al. [18]. Stool samples (𝑛 = 2, children
≤ 5 years old) were collected from theDepartment ofMedical
Microbiology and Parasitology, HUSM, Malaysia, and were
pretested for the presence of amplifiable Shigella DNA by
pentaplex PCR and found to be negative. Five grams of stool
were weighed and suspended in 45 mL of normal saline (NS)
solution, which corresponds to a 10% mixture. The solution
was vortexed for 2min to obtain a homogenous mixture.
Insoluble particulate matter was removed by low-speed
centrifugation (1000×g) for 3min, and the supernatant was
transferred to a fresh tube. Meanwhile, an overnight culture
of Shigella-specific strains was grown in nutrient broth (NB)
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(Oxoid Ltd., UK) under shaking condition (200 rpm). The
bacterial count was estimated to be 108 CFU and 10-fold
diluted with NS. Next, a 500𝜇L sample of each dilution of
bacterial cells wasmixed with 500𝜇L of the faecal suspension
in a new tube. Tubes were vortexed, 1 mL of the mixture
was transferred to 9 mL of GNB (Merck, Germany), and the
mixture was preincubated at 37 ± 237 ± 2∘C for up to 6 h
without shaking. At time 0, 2, 4, and 6 h after incubation,
200𝜇L of mixture was placed in a 0.5mL microcentrifuge
tube and centrifuged at 8000×g for 3min. The supernatant
was removed, cells were washed using NS, and lysates were
prepared by the boiling method. Twomicroliters of the lysate
supernatant were used for pentaplex PCR evaluation.
2.7. Screening of Clinical Specimens. Stool samples were col-
lected from patients suspected with acute gastroenteritis or
dysentery from Department of Medical Microbiology and
Parasitology, USM,Malaysia. Approximately 1 g of each faecal
sample from 30 patients suspected of dysentery was trans-
ferred to 9mL of GNB broth corresponding to 10% mixture
and preincubated at 37∘C ± 2∘C for 4 h without shaking.
Subsequently, 200𝜇L of the suspension was taken out and
placed in 0.5mL microcentrifuge tube and centrifuged at
8000×g for 3min. The supernatant was discarded and cells
were washed with 200 𝜇L of 0.9% NS. Pellet was resuspended
with 30 𝜇L of PCR grade water and boiled for 5min. Two
microlitres of the supernatant containing DNA (lysate) were
used for thermostabilized multiplex PCR evaluation. A pure
culture of strain and a Shigella spiked faecal sample served
as positive controls whilst a PCR reaction mixture without
bacterial DNA template and an unspiked faecal sample from
a healthy individual were incorporated as negative controls.
3. Results
We developed a pentaplex PCR assay that simultaneously
amplifies four specific genes and one internal control gene in a
single reaction; this assay allows detection and differentiation
of Shigella at the genus and species levels (Table 1). Based
on the compatibility of the primers for different genes,
the pentaplex PCR was standardized for the invC (genus
Shigella), rfc (S. flexneri), wbgZ (S. sonnei), and rfpB (S.
dysenteriae) genes. The fifth primer set (ompA) was used for
amplification of the internal control to validate the reliability
of the assay and to exclude false negative results. Figure 1
shows a representative gel that illustrates differentiation of
Shigella by genus and species.
All of the primers were positive for the genes targeted by
pentaplex PCR but negative for non-Shigella strains (Table 2).
The optimum concentration of primer needed to amplify
uniformly with approximately the same band intensity was
0.4 pmol for ompA, rfc, and rfpB; 0.3 pmol for invC; and
0.2 pmol for wbgZ. The pentaplex PCR gave the best results
when 2.5mM MgCl
2
, 200𝜇M dNTPs, and 1U Taq poly-
merase were used. The optimal annealing temperature was
60∘C.
The pentaplex PCR assay was evaluated for analytical
specificity and sensitivity. At the DNA level sensitivity was
100 pg of DNA (Figure 2) and at the bacterial level it was
5.4 × 104 CFU/mL or approximately 120CFU per reaction
mixture of bacteria (Figure 3).The analytical specificity of the
pentaplex PCR assay was evaluated using 120 clinical strains
of Shigella spp. (95 S. flexneri, 20 S. sonnei, 3 S. dysenteriae,
and 2 S. boydii), 10 Gram positive strains, and 27 Gram
negative strains (Table 2).
Of the 120 Shigella strains tested, 116 were positive for
invC. Of the 20 strains of S. sonnei, 16 were positive for
wbgZ. The fact that four strains were wbgZ and invC negative
suggests that the virulence plasmid might have been lost
due to long storage time or subculturing [24]. The rfc and
rfpB primers showed 100% sensitivity in identifying their
respective strains (Table 3).
TheDNA sequencing results of the PCR amplicons for the
four geneswere aligned usingVectorNTI version 9.0 software
and then analyzed by BLAST.The results showed that all four
PCRampliconswere specific to their respective genes andhad
100% sequence identitywith the existingGenBank sequences.
The effect of enrichment for Shigella count was investi-
gated by spiking normal stool samples with known Shigella
numbers and incubating the mixture in growth medium.
The sample inoculated with 103 CFU/mL did not generate
any amplicon at time zero (before incubation); however
S. flexneri, S. sonnei, and S. dysenteriae produced clear
amplicons after 4 h of incubation. This result illustrates that
it is possible to detect Shigella spp. from samples containing
low bacterial concentration by preincubating the samples
in growth medium. A preliminary study on the efficacy
of the multiplex PCR assay was evaluated using 30 faecal
samples whichwere culturally confirmed negative for Shigella
spp. No target genes were amplified in the multiplex PCR
assay although both the positive and internal controls had
amplifications.
4. Discussion
Shigellosis is the most communicable of the bacterial diar-
rhoeas [11]. This disease occurs as sporadic cases and occa-
sional outbreaks of varying magnitude in developed coun-
tries and causes epidemics and endemic disease in developing
countries. Because shigellosis is highly contagious, it is crucial
to develop a rapid method for identifying the bacteria in
order to limit and control outbreaks. Classical methods for
determining the presence of bacteria in general are time
consuming and labor intensive and have low sensitivity [16,
17, 25–27]. Hence, molecular methods, which offer speed,
sensitivity, and specificity, have been developed to address
this problem. However, some of these methods are relatively
expensive and difficult to perform and require special equip-
ment (e.g., a method combining immunocapture with PCR
of bacteria for the detection of Shigella spp. [28], seminested
PCR [29], PCR-nonradioactive labeling [30], PCR-RFLP [31],
and PCR-ELISA [32]). On the other hand, DNA microarray
analysis proved to be specific, sensitive, and reproducible,
but its application as a diagnostic or epidemiological tool is
difficult in view of the elevated cost, instruments and requires
a skilled person to perform the test [33].
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Table 2: Bacterial species and strains used in this study and results of pentaplex PCR.
Bacterial strains No. of strains tested inv 𝐶a rfc wbgZ rfpB IC (ompA)
S. flexneri (ATCC 12022)b 1 + + − − +
S. sonnei (SH031)c 1 + − + − +
S. boydii (ATCC 9207)b 1 + − − − +
S. dysenteriae (SD375)d 1 + − − + +
Salmonella spp. 2 − − − − +
S. Typhic 3 − − − − +
S. Paratyphi Ac 1 − − − − +
S. Paratyphi Bc 1 − − − − +
Klebsiella spp.c 2 − − − − +
K. 𝑝𝑛𝑒𝑢𝑚𝑜𝑛𝑖𝑎𝑒c 2 − − − − +
E. coli (EPEC)c 1 − − − − +
E. coli (EHEC)c 1 − − − − +
E. coli (ETEC)c 1 − − − − +
E. 𝑐𝑜𝑙𝑖c 4 − − − − +
V. 𝑐ℎ𝑜𝑙𝑒𝑟𝑎𝑒c 3 − − − − +
V. 𝑝𝑎𝑟𝑎ℎ𝑒𝑚𝑜𝑙𝑦𝑡𝑖𝑐𝑢𝑠c 1 − − − − +
V. 𝑓𝑢𝑙𝑣𝑎𝑙𝑖𝑠c 1 − − − − +
V. cholera (wild type)c 1 − − − − +
V. 𝑓𝑢𝑟𝑛𝑖𝑠𝑠𝑖𝑖c 1 − − − − +
P. 𝑎𝑒𝑟𝑢𝑔𝑖𝑛𝑜𝑠𝑎c 3 − − − − +
P.𝑚𝑖𝑟𝑎𝑏𝑖𝑙𝑖𝑠c 1 − − − − +
P. 𝑣𝑢𝑙𝑔𝑎𝑟𝑖𝑠c 1 − − − − +
C. 𝑓𝑟𝑒𝑢𝑑𝑖𝑖𝑐 1 − − − − +
E. 𝑐𝑙𝑜𝑎𝑐𝑎𝑒c 1 − − − − +
Y. 𝑒𝑛𝑡𝑒𝑟𝑜𝑐𝑜𝑙𝑖𝑡𝑖𝑐𝑎c 1 − − − − +
Acinetobacter spp.c 1 − − − − +
A. 𝑏𝑎𝑢𝑚𝑎𝑛𝑛𝑖𝑖c 1 − − − − +
S.𝑚𝑎𝑟𝑐𝑒𝑠𝑐𝑒𝑛𝑠c 1 − − − − +
Campylobacter spp.c 1 − − − − +
A. ℎ𝑦𝑑𝑟𝑜𝑝ℎ𝑖𝑙𝑎c 1 − − − − +
M.𝑚𝑜𝑟𝑔𝑎𝑛𝑖𝑖c 1 − − − − +
B. 𝑐𝑒𝑟𝑒𝑢𝑠c 1 − − − − +
S. 𝑎𝑢𝑟𝑒𝑢𝑠c 2 − − − − +
Methylene resistant S. 𝑎𝑢𝑟𝑒𝑢𝑠c 1 − − − − +
Streptococcus spp. Group Ac 1 − − − − +
Streptococcus spp. Group Bc 1 − − − − +
Streptococcus spp. Group Gc 1 − − − − +
Corynebacterium spp.c 1 − − − − +
Listeria spp.c 1 − − − − +
Lactobacillus spp.c 1 − − − − +
Gardnerella spp.c 1 − − − − +
aShigella genus.
bReference strains from American Type Culture Collection (ATCC), Reston, VA, USA.
cDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia.
dObtained from Institute for Medical Research, Malaysia.
“+” is positive; “–” is negative by pentaplex PCR.
To overcome these drawbacks of existing techniques,
we developed a pentaplex PCR assay and evaluated its
ability to detect and identify three enteropathogenic bacteria
species at the genus and species levels. Several previous
studies described the development of Shigella multiplex
PCR, but those assays did not discriminate between Shigella
at the genus and species levels, nor did they differentiate
Shigella from closely related pathogens such as Salmonella,
Citrobacter, and enteroinvasive Escherichia coli (EIEC)
[20, 25, 34].
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Figure 2: Analytical sensitivity of multiplex PCR at genomic DNA level using reference strains. Lane 1, 100 bp plus marker; lane 2, positive
control; lane 3, 100 ng/𝜇L of genomic DNA S. flexneri; lane 4, 10 ng/𝜇L of genomic DNA S. flexneri; lane 5, 1 ng/𝜇L of genomic DNA S. flexneri;
lane 6, 100 pg/𝜇L of genomic DNA S. flexneri; lane 7, 10 pg/𝜇L of genomic DNA S. flexneri; lane 8, 1 pg/𝜇L of genomic DNA S. flexneri; lane
9, 100 bp plus marker; lane 10, positive control ; lane 11, 100 ng/𝜇L of genomic DNA S. sonnei; lane 12, 10 ng/𝜇L of genomic DNA S. sonnei;
lane 13, 1 ng/𝜇L of genomic DNA S. sonnei; lane 14, 100 pg/𝜇L of genomic DNA S. sonnei; lane 15, 10 pg/𝜇L of genomic DNA S. sonnei; lane 16,
1 pg/𝜇L of genomic DNA S. sonnei; lane 17, 100 bp plus marker; lane 18, positive control ; lane 19, 100 ng/𝜇L of genomic DNA S. dysenteriae;
lane 20, 10 ng/𝜇L of genomic DNA S. dysenteriae; lane 21, 1 ng/𝜇L of genomic DNA S. dysenteriae; lane 22, 100 pg/𝜇L of genomic DNA S.
dysenteriae; lane 23, 10 pg/𝜇L of genomic DNA S. dysenteriae; lane 24, 1 pg/𝜇L of genomic DNA S. dysenteriae; lane 25, 100 bp plus marker.
1000 bp
500 bp
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211 bp S. flexneri S. sonnei S. dysenteriae
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Figure 3: Analytical sensitivity of multiplex PCR at the bacterial level (CFU/mL) using reference strains. Lane 1, 100 bp plus marker; lane 2,
positive control; lane 3, 108 CFU/mL lysate of S. flexneri; lane 4, 107 CFU/mL lysate of S. flexneri; lane 5, 106 CFU/mL lysate of S. flexneri; lane
6, 105 CFU/mL lysate of S. flexneri; lane 7, 104 CFU/mL lysate of S. flexneri; lane 8, 103 CFU/mL lysate of S. flexneri; lane 9, 102 CFU/mL lysate
of S. flexneri; lane 10, 100 bp plus Marker; lane 11, 108 CFU/mL lysate of S. sonnei; lane 12, 107 CFU/mL lysate of S. sonnei; lane 13, 106 CFU/mL
lysate of S. sonnei; lane 14, 105 CFU/mL lysate of S. sonnei; lane 15, 104 CFU/mL lysate of S. sonnei; lane 16, 103 CFU/mL lysate of S. sonnei;
lane 17, 102 CFU/mL lysate of S. sonnei; lane 18, 100 bp plus Marker; lane 19, Positive control ; lane 20, 108 CFU/mL lysate of S. dysenteriae;
lane 21, 107 CFU/mL lysate of S. dysenteriae; lane 22, 106 CFU/mL lysate of S. dysenteriae; lane 23, 105 CFU/mL lysate of S. dysenteriae; lane 24,
104 CFU/mL lysate of S. dysenteriae; lane 25, 103 CFU/mL lysate of S. dysenteriae; lane 26, 102 CFU/mL lysate of S. dysenteriae; lane 27, 100 bp
plus marker.
In our study, primers were designed based on the preva-
lent species responsible for the majority of shigellosis cases
[2, 4, 6, 7]. Four highly specific genes (invC, rfc, wbgZ,
and rfpB) that can best detect Shigella at the genus and
species level were identified. Because invC is present among
all of the Shigella spp., rfc, wbgZ, and rfpB were combined
with invC for speciation of the Shigella strains. The primer
for S. flexneri that targets the rfc gene was designed based
on Houng et al. [18], and it allows discrimination between
Shigella and EIEC in faecal samples. Similarly, the three
other highly specific primers were designed based on the
homologous sequences retrieved from GenBank (NCBI). S.
boydii species identification was not included in this study
because of its low prevalence in developing and industrialized
countries. However, the presence of the invC band specific for
Shigella genus and the absence of all other amplicons specific
for Shigella spp. can be considered to be the detection criteria
for S. boydii.
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Table 3: Summary for evaluation of pentaplex PCR assay carried
out using reference strains.
Number of strains evaluated by pentaplex PCR assay
Bacterial strains No. of specimen tested Positive (%) (𝑛 = 120)
Shigella genus 120 116 (96.7%)
S. flexneri 95 95 (100%)
S. sonnei 20 16 (80%)
S. dysenteriae 3 3 (100%)
Following the successful application of the primers indi-
vidually, they were mixed to produce the pentaplex PCR.
The mixing of primers in a single tube decreases costs and
time and increases the ease of the assay. Although numerous
reports of PCR assays for the detection of Shigella spp.
exist [18, 20, 25, 34], only a few of them have incorporated
internal controls to rule out false negatives [35]. According to
guidelines for Molecular Diagnostic Methods for Infectious
Diseases (MM3-A2), incorporation of an internal control in
the reaction is essential for the diagnostic test to exclude
false negative result or the presence of inhibitors. In the
present study, inclusion of a 1319 bp internal control in the
pentaplex PCR assay helped us to rule out false negatives
or PCR inhibitors. The primers were designed with great
care; BLAST and alignment results of the sequence confirmed
that it did not cross-react with closely related species such
as enteroinvasive Escherichia coli (EIEC) which gives rise to
similar illness as shigellosis. However, it was unfortunate that
EIEC strain was not available to be tested in this study.
The pentaplex PCR developed in our study successfully
amplified all five amplicons from a single reaction tube, and
the primers did not interact with each other to produce false
negatives. Compatibility of primerswith target ampliconswas
confirmed by sequencing the PCR products derived from
the five representative strains. The pentaplex mixture was
tested with 120 clinical strains and also against other Gram
positive and Gram negative strains to determine the primers’
specificity. The primers were found to be highly specific in
identifying Shigella spp. However, in some cases nonspecific
amplicon was weak and fell outside the expected size range
for the primers applied and therefore was of no concern.
These nonspecific amplifications are likely due to low levels
of nonspecific binding between the primers and the bacterial
genomic DNA.
The presence of PCR inhibitors in stool samples (e.g.,
bilirubin, bile salts, and heme in the faeces) may inhibit
amplification and limit the usefulness of PCR technique
[36, 37]. As reported by Theron et al. [29] and Thong et al.
[20], an enrichment procedure prior to PCR enhances the
total number of bacteria present, which helps to dilute the
PCR inhibitory substances. As stated by the manufacturer
of Gram negative broth (GNB), citrate and deoxycholate in
the broth act as selective agents and suppress the growth of
Gram positive organisms, including some coliform bacteria.
The additional step of preincubating spiked faecal sample
in GNB helps to eliminate the natural inhibitors and could
enhance the viability of Shigella spp. in samples [29, 38].
A preliminary study with clinical specimens showed no
cross reaction with other non-Shigella strains, however, to
check the real performance of the developed test, a larger
positive sample size need to be further investigated. The
4 h enrichment step would increase the total number of
bacteria present and enhance the sensitivity of the assay. The
sensitivity level achieved in our study was comparable to that
of other studies. For example, Houng et al. [18] detected up to
7.4 × 104 CFU/mL of Shigella by amplifying IS 630 sequences,
Yavzori et al. [39] detected at 104 CFU of Shigella per gram
of faeces with the use of virF primers, and Thong et al. [20]
reported a detection level of 5.0 × 104 CFU/mL of Shigella by
amplifying ial and ipaH sequences in Shigella spp. Thus, the
average detection of pentaplex PCR described in this study
(5.4 × 104 CFU/mL) is within the common detection limit for
Shigella.
5. Conclusion
In conclusion, the pentaplex PCR assay developed in this
study was able to detect four genes that are essential for
the detection and differentiation of Shigella at the genus and
species levels simultaneously in a single test within 4 h. The
built-in internal control in this assay prevented false negative
results. The pentaplex PCR assay was highly sensitive and
could provide results on the same day that a specimen was
submitted for evaluation, which is critical during outbreaks.
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